Literature DB >> 22460414

Mechanisms of muscle wasting in sarcopenia.

Vivian de Oliveira Nunes Teixeira1, Lidiane Isabel Filippin, Ricardo Machado Xavier.   

Abstract

Approximately 66% of the patients with rheumatoid arthritis (RA) have significant loss of cell mass (rheumatoid cachexia), mainly of skeletal muscle (rheumatoid sarcopenia). Sarcopenia is defined as muscle wasting associated with functional impairment. Patients with RA possess significant reduction in muscle strength, caused by muscle protein wasting, and loss of functionality. Various conditions leading to muscle wasting involve different pathways of intracellular signaling that trigger: (i) programmed cell death (apoptosis); (ii) increased protein degradation through autophagy, calcium-dependent proteases (calpains and caspases), and proteasome system; (iii) decreased satellite cell activation, responsible for muscle regeneration. This article aimed at reviewing these general mechanisms of sarcopenia and their involvement in RA. Greater knowledge of these mechanisms may lead to the development of innovative therapies to this important comorbidity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460414

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN: 0482-5004


  13 in total

1.  Lack of association of the autophagy-related gene polymorphism ATG16L1 rs2241880 in RA predisposition.

Authors:  Anthoula Chatzikyriakidou; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Rheumatol Int       Date:  2013-03-28       Impact factor: 2.631

2.  Protein Hydrolysate from Spirulina platensis Prevents Dexamethasone-Induced Muscle Atrophy via Akt/Foxo3 Signaling in C2C12 Myotubes.

Authors:  Chi-Woo Lee; Yeok Boo Chang; Chun Woong Park; Sung Hee Han; Hyung Joo Suh; Yejin Ahn
Journal:  Mar Drugs       Date:  2022-05-29       Impact factor: 6.085

Review 3.  Novel excitation-contraction coupling related genes reveal aspects of muscle weakness beyond atrophy-new hopes for treatment of musculoskeletal diseases.

Authors:  Heather Manring; Eduardo Abreu; Leticia Brotto; Noah Weisleder; Marco Brotto
Journal:  Front Physiol       Date:  2014-02-18       Impact factor: 4.566

4.  Dual role of the caspase enzymes in satellite cells from aged and young subjects.

Authors:  S Fulle; S Sancilio; R Mancinelli; V Gatta; R Di Pietro
Journal:  Cell Death Dis       Date:  2013-12-12       Impact factor: 8.469

5.  Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors.

Authors:  Laura Di Renzo; Santo Gratteri; Francesca Sarlo; Andrea Cabibbo; Carmen Colica; Antonino De Lorenzo
Journal:  Dis Markers       Date:  2014-10-13       Impact factor: 3.434

6.  Associations between low back pain, urinary incontinence, and abdominal muscle recruitment as assessed via ultrasonography in the elderly.

Authors:  Vânia F Figueiredo; Juleimar S C Amorim; Aline M Pereira; Paulo H Ferreira; Leani S M Pereira
Journal:  Braz J Phys Ther       Date:  2015-02-13       Impact factor: 3.377

Review 7.  The Role of Inflammation in Age-Related Sarcopenia.

Authors:  Sebastiaan Dalle; Lenka Rossmeislova; Katrien Koppo
Journal:  Front Physiol       Date:  2017-12-12       Impact factor: 4.566

8.  Muscle wasting in osteoarthritis model induced by anterior cruciate ligament transection.

Authors:  Jordana Miranda de Souza Silva; Paulo Vinicius Gil Alabarse; Vivian de Oliveira Nunes Teixeira; Eduarda Correa Freitas; Francine Hehn de Oliveira; Rafael Mendonça da Silva Chakr; Ricardo Machado Xavier
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

9.  Temporal development of muscle atrophy in murine model of arthritis is related to disease severity.

Authors:  Lidiane I Filippin; Vivian N Teixeira; Paula R Viacava; Priscila S Lora; Laura L Xavier; Ricardo M Xavier
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-02-07       Impact factor: 12.910

10.  Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis.

Authors:  Meltem Alkan Melikoğlu
Journal:  Arch Rheumatol       Date:  2017-01-18       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.